Does RELUGOLIX Cause Neoplasm malignant? 27 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Neoplasm malignant have been filed in association with RELUGOLIX (Orgovyx). This represents 0.1% of all adverse event reports for RELUGOLIX.
27
Reports of Neoplasm malignant with RELUGOLIX
0.1%
of all RELUGOLIX reports
5
Deaths
8
Hospitalizations
How Dangerous Is Neoplasm malignant From RELUGOLIX?
Of the 27 reports, 5 (18.5%) resulted in death, 8 (29.6%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RELUGOLIX. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does RELUGOLIX Cause?
Hot flush (6,845)
Fatigue (5,203)
Therapy interrupted (3,251)
Incorrect dose administered (1,917)
Asthenia (1,718)
Arthralgia (1,385)
Diarrhoea (1,383)
Product dose omission issue (1,189)
Dizziness (1,146)
Constipation (902)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which RELUGOLIX Alternatives Have Lower Neoplasm malignant Risk?
RELUGOLIX vs REMDESIVIR
RELUGOLIX vs REMERON
RELUGOLIX vs REMICADE
RELUGOLIX vs REMIFENTANIL
RELUGOLIX vs REMIMAZOLAM